CFO moves W42 2026: 17 filings, pharma leads, interim share at 23.5%

The week at a glance

SEC filings recorded 17 CFO moves between 2026-10-12 and 2026-10-18, bringing the October month-to-date total to 44. The 17 moves broke down as 3 appointments, 6 transitions, 4 interim designations, and 4 departures. Interim appointments accounted for 23.5% of the week's activity. Of the 13 seats filled, 5 came from internal promotions, 5 from external hires, and 3 could not be established from the filings. Among the incoming CFOs, 0 were identified as first-time CFOs, 3 were confirmed to have held the role before, and the status of the remaining 10 was not established.

Pharmaceutical Preparations was the busiest sector with 3 moves, covering Niki BioSolutions, Inc., Actinium Pharmaceuticals, Inc., and CalciMedica, Inc.. Two additional moves came from a sector not on the roster. All other sectors represented contributed 1 move each.

Notable individual moves

Union Pacific Corporation filed a departure for Jennifer L. Hamann with no effective date stated in the filing. Emergent BioSolutions Inc. designated Frank Vargo as interim CFO in place of Richard Lindahl, with an effective date of 2027-01-01, the furthest-dated change of the week. Super Micro Computer, Inc. recorded a transition from David Weigand to Mark Long, effective 2026-10-14. Hyster-Yale, Inc. named Matthew Cornell to succeed Rajiv K. Prasad effective 2026-11-01, and Dauch Corporation set a 2026-12-01 effective date for Nathan R. Iles to take over from Christopher May.

On the departure side, Verra Mobility Corporation reported Craig Conti's departure effective 2026-11-04 with no successor named, and WidePoint Corporation recorded Robert George's exit effective 2026-09-30, also without a named replacement. Median tenure at departure is not available, as 0 departures this week had known tenure on record.